National Asset Management, Inc. Amarin Corp Plcuk Transaction History

National Asset Management, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	BUY	$1.12 - $1.49 $56,182 - $74,742	50,163 Added 325.1%	65,593 $78,000
Q1 2023 May 17, 2023	BUY	$1.19 - $2.19 $4,522 - $8,322	3,800 Added 32.67%	15,430 $23,000
Q4 2022 Feb 21, 2023	BUY	$1.07 - $1.34 $12,444 - $15,584	11,630 New	11,630 $14,000
Q4 2020 Feb 04, 2021	SELL	$4.04 - $5.31 $60,297 - $79,251	-14,925 Closed	0 $0
Q3 2020 Nov 09, 2020	SELL	$3.64 - $7.76 $9,828 - $20,952	-2,700 Reduced 15.32%	14,925 $63,000
Q2 2020 Jul 31, 2020	BUY	$4.78 - $8.26 $84,247 - $145,582	17,625 New	17,625 $122,000
Q4 2019 Feb 10, 2020	SELL	$13.94 - $24.12 $377,077 - $652,446	-27,050 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$13.89 - $23.16 $172,236 - $287,184	12,400 Added 84.64%	27,050 $411,000
Q2 2019 Aug 05, 2019	BUY	$16.27 - $20.51 $29,286 - $36,918	1,800 Added 14.01%	14,650 $285,000
Q1 2019 May 08, 2019	BUY	$12.61 - $22.33 $162,038 - $286,940	12,850 New	12,850 $267,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $222M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on National Asset Management, Inc. with notifications on news.